Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Scynexis Inc (SCYX)  
$1.54 0.07 (4.76%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 23,951,000
Market Cap: 36.88(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.39 - $3.645
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   SCYNEXIS is a biotechnology company. Co. is developing its main product candidate, ibrexafungerp, as an intravenous/oral agent for multiple fungal indications in both the community and hospital settings. The U.S. Food and Drug Administration has approved BREXAFEMME (ibrexafungerp tablets) for treatment of patients with vulvovaginal candidiasis, also known as vaginal yeast infection, and Co. has commenced the commercialization of BREXAFEMME in the U.S. Co. also is continuing late-stage clinical development of ibrexafungerp for multiple indications, including the treatment of invasive fungal infections caused by Candida spp. (including C. auris) and Aspergillus spp. in hospitalized patients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 132
  Page 5 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sanofi-Aventis 10% Owner   –       –       •   2014-05-07 3 IO $0.00 $0 I/I 0 1,677,057     -
   F.c.p.r. Genavent 10% Owner   –       –       •   2014-05-07 4 B $10.00 $100,000 D/D 10,000 237,598 2.45     -
   F.c.p.r. Genavent 10% Owner   –       –       •   2014-05-07 4 A $0.00 $0 D/D 213,595 227,598     -
   F.c.p.r. Genavent 10% Owner   –       –       •   2014-05-07 4 OE $0.20 $2,801 D/D 14,003 14,003     -
   Arthaud Laurent Director   –       •      –    2014-05-07 4 A $0.00 $0 I/I 479 4,507     -
   Arthaud Laurent Director   –       •      –    2014-05-07 4 OE $0.20 $58 I/I 290 4,028     -
   Fcpr Biotechnology Fund 10% Owner   –       –       •   2014-05-07 4 B $10.00 $500,000 D/D 50,000 295,077 2.45     -
   Fcpr Biotechnology Fund 10% Owner   –       –       •   2014-05-07 4 A $0.00 $0 D/D 208,577 245,077     -
   Fcpr Biotechnology Fund 10% Owner   –       –       •   2014-05-07 4 OE $0.20 $7,300 D/D 36,500 36,500     -
   Nothias Jean-Yves Director   –       •      –    2014-05-07 4 B $10.00 $500,000 I/I 50,000 295,077 2.1     -
   Nothias Jean-Yves Director   –       •      –    2014-05-07 4 A $0.00 $0 I/I 208,577 245,077     -
   Nothias Jean-Yves Director   –       •      –    2014-05-07 4 OE $0.20 $7,300 I/I 36,500 36,500     -
   Champsi Farah 10% Owner   –       –       •   2014-05-07 4 B $10.00 $319,340 I/I 31,934 45,736 1.5     -
   Champsi Farah 10% Owner   –       –       •   2014-05-07 4 A $0.00 $0 I/I 10,421 13,802     -
   Champsi Farah 10% Owner   –       –       •   2014-05-07 4 OE $0.20 $676 I/I 3,381 3,381     -
   Champsi Farah 10% Owner   –       –       •   2014-05-07 4 B $10.00 $8,680,660 D/D 868,066 1,240,575 2.45     -
   Champsi Farah 10% Owner   –       –       •   2014-05-07 4 A $0.00 $0 D/D 280,953 372,509     -
   Champsi Farah 10% Owner   –       –       •   2014-05-07 4 OE $0.20 $18,311 D/D 91,556 91,556     -
   Ribeill Yves J President and CEO   •       •      –    2014-05-07 4 A $0.00 $0 D/D 595 1,190     -
   Ribeill Yves J President and CEO   •       •      –    2014-05-07 4 OE $0.20 $119 D/D 595 595     -
   Ventech Capital Ii 10% Owner   –       –       •   2014-05-07 4 B $10.00 $280,000 D/D 28,000 414,211 2.45     -
   Ventech Capital Ii 10% Owner   –       –       •   2014-05-07 4 A $0.00 $0 D/D 314,497 386,211     -
   Ventech Capital Ii 10% Owner   –       –       •   2014-05-07 4 OE $0.20 $14,343 D/D 71,714 71,714     -
   Kirby Pamela J Director   –       •      –    2014-05-07 4 A $0.00 $0 D/D 12,745 25,590     -
   Kirby Pamela J Director   –       •      –    2014-05-07 4 OE $0.20 $2,549 D/D 12,745 12,745     -
  132 Records found
  1  2  3  4  5  6   
  Page 5 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us